Cibus, Inc. CBUS

CBUS Company Overview

Cibus, Inc. (NASDAQ: CBUS) is an agricultural biotechnology company focused on developing and commercializing plant traits for major row crops using gene-editing and precision breeding technologies. The company operates within the agricultural biotechnology and seed-trait industries, with an emphasis on improving crop productivity, herbicide tolerance, disease resistance, and sustainability-related characteristics. Its core commercial focus has centered on traits for crops such as canola, rice, soybean, and wheat.

The company’s primary revenue drivers have historically included trait licensing arrangements, collaboration agreements, and technology development activities rather than large-scale seed sales. Cibus positions itself as a technology-driven trait developer that works with seed companies and agricultural partners to integrate proprietary traits into commercial germplasm. A key element of its strategy is the use of its proprietary gene-editing platform, often referred to in company materials as the Rapid Trait Development System (RTDS) and related high-throughput trait development capabilities. Cibus traces its origins to biotechnology research operations founded in the early 2000s and later became a publicly traded company through a business combination involving Calyxt, Inc. and legacy Cibus operations.